Amgen Can't Dodge Kickback Claims In Aranesp Suit
Amgen Inc. on Friday lost a bid for summary judgment in a Massachusetts whistleblower suit alleging the company and others bribed health care providers to purchase Aranesp, but ruled that the...To view the full article, register now.
Already a subscriber? Click here to view full article